The Ministry of Health and Family Welfare (MoHFW) has published Indian Council of Medical Research’s (ICMR) Guidelines for Ethical use of Leftover De-identified/ Anonymous Samples for Commercial Purpose. These specimens include organs, parts of organs, cells, tissues, cell products such as blood, blood products (even positive for eHBsAG/HCV/HIV/Syphilis and expired blood), urine, saliva, DNA/RNA, hair, nail clippings, […]

Read More →

The Department of Pharmaceuticals issued the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 on March 13, 2024, with the objective to enhance ethical conduct and bring more transparency to the marketing practices of pharmaceutical companies. Key Features of the Code Attributes Brief Description   Restrictions on Marketing and Promotion of Drugs Drug advertising must […]

Read More →

The Drugs and Cosmetics Act, 1940 and rules 1945 have entrusted various responsibilities to Central and State Government regulators for regulation of drugs and cosmetics. It envisages uniform implementation of the provisions of the Act and Rules made there under for ensuring the safety, rights, and well-being of the patients by regulating the drugs and […]

Read More →

Background India has been suffering surrogacy commercialization for few decades now. Since the concept of Surrogacy is a newly introduced term for the country, neither there was statutory legislation to regulate, nor there realization to have one. To contribute more to the thought process, Surrogacy was not even socially accepted in the country and this […]

Read More →

In line with Order bearing No 40-3/2020-DM-I(A) dated 23rd April 2021, read along with guidelines for effective control of Covid 19 issued by Ministry of Home Affairs under Disaster Management Act 2005, whereas the medical oxygen is an essential public health commodity and availability of adequate and uninterrupted supply of Medical Oxygen is an important pre-requisite for managing […]

Read More →